Huntington Disease

"Huntington Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)

Descriptor ID	D006816
MeSH Number(s)	C10.228.140.079.545 C10.228.140.380.278 C10.228.662.262.249.750 C10.574.500.497 C16.320.400.430 F03.615.250.400 F03.615.400.390
Concept/Terms	Huntington Disease Huntington Disease Huntington Chorea Chorea, Huntington Huntington's Disease Chronic Progressive Hereditary Chorea (Huntington) Huntington Chronic Progressive Hereditary Chorea Progressive Chorea, Chronic Hereditary (Huntington) Progressive Chorea, Hereditary, Chronic (Huntington) Huntington's Chorea Chorea, Huntington's Chorea, Chronic Progressive Hereditary (Huntington) Huntington Disease, Late Onset Huntington Disease, Late Onset Late-Onset Huntington Disease Huntington Disease, Late-Onset Late Onset Huntington Disease Juvenile Huntington Disease Juvenile Huntington Disease Juvenile-Onset Huntington Disease Juvenile Onset Huntington Disease Huntington Disease, Juvenile-Onset Huntington Disease, Juvenile Onset Huntington Disease, Juvenile Akinetic-Rigid Variant of Huntington Disease Akinetic-Rigid Variant of Huntington Disease Akinetic Rigid Variant of Huntington Disease Huntington Disease, Akinetic-Rigid Variant Huntington Disease, Akinetic Rigid Variant

Below are MeSH descriptors whose meaning is more general than "Huntington Disease".

Diseases [C]
Nervous System Diseases [C10]
Central Nervous System Diseases [C10.228]
Brain Diseases [C10.228.140]
Basal Ganglia Diseases [C10.228.140.079]
Huntington Disease [C10.228.140.079.545]
Dementia [C10.228.140.380]
Huntington Disease [C10.228.140.380.278]
Movement Disorders [C10.228.662]
Dyskinesias [C10.228.662.262]
Chorea [C10.228.662.262.249]
Huntington Disease [C10.228.662.262.249.750]
Neurodegenerative Diseases [C10.574]
Heredodegenerative Disorders, Nervous System [C10.574.500]
Huntington Disease [C10.574.500.497]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Genetic Diseases, Inborn [C16.320]
Heredodegenerative Disorders, Nervous System [C16.320.400]
Huntington Disease [C16.320.400.430]
Psychiatry and Psychology [F]
Mental Disorders [F03]
Neurocognitive Disorders [F03.615]
Cognition Disorders [F03.615.250]
Huntington Disease [F03.615.250.400]
Dementia [F03.615.400]
Huntington Disease [F03.615.400.390]

Below are MeSH descriptors whose meaning is related to "Huntington Disease".

Below are MeSH descriptors whose meaning is more specific than "Huntington Disease".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Huntington Disease" by people in this website by year, and whether "Huntington Disease" was a major or minor topic of these publications.

Bar chart showing 20 publications over 12 distinct years, with a maximum of 3 publications in 2001 and 2002 and 2005 and 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	3	0	3
2002	3	0	3
2003	0	1	1
2004	0	1	1
2005	3	0	3
2006	1	0	1
2007	1	2	3
2008	1	0	1
2011	1	0	1
2012	0	1	1
2022	1	0	1
2025	1	0	1

Below are the most recent publications written about "Huntington Disease" by people in Profiles.

Schriger SH, Nurse CN, O'Hayer CV. Acceptance and commitment therapy with Huntington's disease: A narrative review and case report of a caregiver-assisted intervention. J Huntingtons Dis. 2025 Feb; 14(1):3-15.

View in: PubMed
Zhi L, Zhao J, Jaffe D, Chen Y, Wang N, Qin Q, Seifert EL, Li C, Zhang H. Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice. J Vis Exp. 2022 Jun 08; (184).

View in: PubMed
Miller EG, Laragione G, Kang TI, Feudtner C. Concurrent care for the medically complex child: lessons of implementation. J Palliat Med. 2012 Nov; 15(11):1281-3.

View in: PubMed
Gupta S, Jie S, Colby DW. Protein misfolding detected early in pathogenesis of transgenic mouse model of Huntington disease using amyloid seeding assay. J Biol Chem. 2012 Mar 23; 287(13):9982-9.

View in: PubMed
Dragatsis I, Goldowitz D, Del Mar N, Deng YP, Meade CA, Liu L, Sun Z, Dietrich P, Yue J, Reiner A. CAG repeat lengths > or =335 attenuate the phenotype in the R6/2 Huntington's disease transgenic mouse. Neurobiol Dis. 2009 Mar; 33(3):315-30.

View in: PubMed
Reiner A, Del Mar N, Deng YP, Meade CA, Sun Z, Goldowitz D. R6/2 neurons with intranuclear inclusions survive for prolonged periods in the brains of chimeric mice. J Comp Neurol. 2007 Dec 20; 505(6):603-29.

View in: PubMed
Gibb SL, Boston-Howes W, Lavina ZS, Gustincich S, Brown RH, Pasinelli P, Trotti D. A caspase-3-cleaved fragment of the glial glutamate transporter EAAT2 is sumoylated and targeted to promyelocytic leukemia nuclear bodies in mutant SOD1-linked amyotrophic lateral sclerosis. J Biol Chem. 2007 Nov 2; 282(44):32480-90.

View in: PubMed
Bogush A, Pedrini S, Pelta-Heller J, Chan T, Yang Q, Mao Z, Sluzas E, Gieringer T, Ehrlich ME. AKT and CDK5/p35 mediate brain-derived neurotrophic factor induction of DARPP-32 in medium size spiny neurons in vitro. J Biol Chem. 2007 Mar 9; 282(10):7352-9.

View in: PubMed
Metzger S, Bauer P, Tomiuk J, Laccone F, Didonato S, Gellera C, Mariotti C, Lange HW, Weirich-Schwaiger H, Wenning GK, Seppi K, Melegh B, Havasi V, Balik? L, Wieczorek S, Zaremba J, Hoffman-Zacharska D, Sulek A, Basak AN, Soydan E, Zidovska J, Kebrdlova V, Pandolfo M, Riba? P, Kadasi L, Kvasnicova M, Weber BH, Kreuz F, Dose M, Stuhrmann M, Riess O. Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease. Hum Genet. 2006 Sep; 120(2):285-92.

View in: PubMed
Metzger S, Bauer P, Tomiuk J, Laccone F, Didonato S, Gellera C, Soliveri P, Lange HW, Weirich-Schwaiger H, Wenning GK, Melegh B, Havasi V, Balik? L, Wieczorek S, Arning L, Zaremba J, Sulek A, Hoffman-Zacharska D, Basak AN, Ersoy N, Zidovska J, Kebrdlova V, Pandolfo M, Riba? P, Kadasi L, Kvasnicova M, Weber BH, Kreuz F, Dose M, Stuhrmann M, Riess O. The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease. Neurogenetics. 2006 Mar; 7(1):27-30.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement